Advanced search
Publication Cover
Bioanalysis Volume 8, 2016 - Issue 22
Submit an article Journal homepage
493
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Fit-For-Purpose Biomarker Immunoassay Qualification and Validation: Three Case Studies

Kyra Cowan1 Genentech, 1 DNA Way, South San Francisco, CA94080, USACorrespondence[email protected]
,
Xiaoying Gao1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
,
Vaishali Parab2 Merck & Co, Inc., 901 South California Ave, Palo Alto, CA94304, USA
,
Trung Nguy1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
,
Lawren Wu3 Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA91320, USA
,
Joseph R Arron1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
,
Michael Townsend1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
,
Jeffrey Wallin1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
,
Melissa Cheu1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
,
Alyssa Morimoto1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
&
Eric Wakshull1 Genentech, 1 DNA Way, South San Francisco, CA94080, USA
 show all
Pages 2329-2340 | Received 01 Jul 2016, Accepted 19 Sep 2016, Published online: 07 Oct 2016

References

  • Hay M , ThomasDW, CraigheadJL, EconomidesC, RosenthalJ. Clinical development success rates for investigational drugs. Nat. Biotechnol. 32 (1), 40–51 (2014).
  • Tan DS , ThomasGV, GarrettMDet al. Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development. Cancer J. 15 (5), 406–420 (2009).
  • Backen AC , CummingsJ, MitchellC, JaysonG, WardTH, DiveC. ‘Fit-for-purpose’ validation of searchlight multiplex elisas of angiogenesis for clinical trial use. J. Immunol. Methods342 (1–2), 106–114 (2009).
  • Chau CH , RixeO, McleodH, FiggWD. Validation of analytic methods for biomarkers used in drug development. Clin. Cancer Res. 14 (19), 5967–5976 (2008).
  • Cummings J , RaynaudF, JonesL, SugarR, DiveC. Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br. J. Cancer103 (9), 1313–1317 (2010).
  • Cummings J , WardTH, DiveC. Fit-for-purpose biomarker method validation in anticancer drug development. Drug Discov. Today15 (19–20), 816–825 (2010).
  • Desilva B , SmithW, WeinerRet al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20 (11), 1885–1900 (2003).
  • Jani D , AllinsonJ, BerishaFet al. Recommendations for use and fit-for-purpose validation of biomarker multiplex ligand binding assays in drug development. AAPS J. 18 (1), 1–14 (2016).
  • Khan MU , BowsherRR, CameronMet al. Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development. Bioanalysis7 (2), 229–242 (2015).
  • Lee JW , DevanarayanV, BarrettYCet al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23 (2), 312–328 (2006).
  • Lee JW , HallM. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (13), 1259–1271 (2009).
  • Lee JW , WeinerRS, SailstadJMet al. Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report. Pharm. Res. 22 (4), 499–511 (2005).
  • US FDA . Guidance for industry. Bioanalytical method validation. www.fda.gov.
  • Brookes K , CummingsJ, BackenAet al. Issues on fit-for-purpose validation of a panel of elisas for application as biomarkers in clinical trials of anti-angiogenic drugs. Br. J. Cancer102 (10), 1524–1532 (2010).
  • Lin M , LassmanME, WeinerR, LaterzaOF. Development and fit-for-purpose validation of a LC–MS/MS assay for fibrinogen peptide a quantitation in human plasma. Bioanalysis6 (13), 1759–1766 (2014).
  • Ni YG , YuanX, NewittJAet al. Development and fit-for-purpose validation of a soluble human programmed death-1 protein assay. AAPS J. 17 (4), 976–987 (2015).
  • Gregg EO , MinetE, McewanM. Urinary biomarkers of smokers’ exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach. Biomarkers18 (6), 467–486 (2013).
  • Robas NM . Use of pd biomarkers to drive dose selection and early clinical decision making. Bioanalysis4 (20), 2485–2497 (2012).
  • Jia G , EricksonRW, ChoyDFet al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J. Allergy Clin. Immunol. 130 (3), 647–654.e10 (2012).
  • Huang YJ , NariyaS, HarrisJMet al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J. Allergy Clin. Immunol. 136 (4), 874–884 (2015).
  • Choy DF , HartKM, BorthwickLAet al. Th2 and th17 inflammatory pathways are reciprocally regulated in asthma. Sci. Transl. Med. 7 (301), 301ra129 (2015).
  • Maude SL , BarrettD, TeacheyDT, GruppSA. Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J. 20 (2), 119–122 (2014).
  • EMA . Committee for Medicinal Products for Human Use (CHMP). Guideline on bioanalytical method validation. London, UK (2011). www.ema.europa.eu.
  • Andreasson U , Perret-LiaudetA, van Waalwijk van DoornLJC. A practical guide to immunoassay method validation. Front. Neurol. 6, 179 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.